[1]
A. Bulu, M. Yalnız, E. Onalan, and E. Donder, “The retrospective evaluation of response to adalimumab and infliximab treatment in patients diagnosed with inflammatory bowel disease”, Med Sci Discov, vol. 9, no. 8, pp. 438–445, Aug. 2022.